Drug Shortage Report for TARO-RABEPRAZOLE

Last updated on 2023-07-18 History
Report ID 173657
Drug Identification Number 02298074
Brand name TARO-RABEPRAZOLE
Common or Proper name RABEPRAZOLE
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-27
Estimated end date 2023-06-30
Actual end date 2023-06-30
Shortage status Resolved
Updated date 2023-07-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2023-07-18 French Compare
v21 2023-07-18 English Compare
v20 2023-04-10 French Compare
v19 2023-04-10 English Compare
v18 2023-03-24 French Compare
v17 2023-03-24 English Compare
v16 2023-03-10 French Compare
v15 2023-03-10 English Compare
v14 2023-02-01 French Compare
v13 2023-02-01 English Compare
v12 2023-01-20 French Compare
v11 2023-01-20 English Compare
v10 2023-01-10 French Compare
v9 2023-01-10 English Compare
v8 2022-12-12 French Compare
v7 2022-12-12 English Compare
v6 2022-11-25 French Compare
v5 2022-11-25 English Compare
v4 2022-11-16 French Compare
v3 2022-11-16 English Compare

Showing 1 to 20 of 22